Triple-negative breast cancer: the reality in Chile and in Latin America
- PMID: 30792810
- PMCID: PMC6372297
- DOI: 10.3332/ecancer.2019.893
Triple-negative breast cancer: the reality in Chile and in Latin America
Abstract
Breast cancer is the leading cause of cancer death among women worldwide. While triple-negative breast cancer is less common among various sub-types of breast cancer, it tends to affect younger women and is more aggressive, having a higher rate of early recurrence and mortality compared to other sub-types. We know about the association between triple-negative breast cancer and BRCA mutations, which are highly prevalent in founding populations of European origin, but the true prevalence of these mutations in Latin American populations is unknown. There is also very little information about the demographic and epidemiological aspects of triple-negative breast cancer in Latin America, which we will try to summarise in this article. In addition, we will try to provide a brief introduction to the most common recommendations for treating this histological class in Latin America.
Keywords: breast cancer; triple-negative breast cancer.
Similar articles
-
Breast cancer in young women in Latin America: an unmet, growing burden.Oncologist. 2013;18 Suppl:26-34. doi: 10.1634/theoncologist.18-S2-26. Oncologist. 2013. PMID: 24334479
-
[Epidemiological transition in Latin America: a comparison of four countries].Rev Med Chil. 1997 Jun;125(6):719-27. Rev Med Chil. 1997. PMID: 9580335 Spanish.
-
Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.Oncologist. 2016 Jul;21(7):832-9. doi: 10.1634/theoncologist.2015-0416. Epub 2016 Jun 10. Oncologist. 2016. PMID: 27286788 Free PMC article. Review.
-
Trends in cervical cancer mortality in the Americas.Bull Pan Am Health Organ. 1996 Dec;30(4):290-301. Bull Pan Am Health Organ. 1996. PMID: 9041740
-
Real-world data on triple-negative breast cancer in Latin America and the Caribbean.Ecancermedicalscience. 2023 Nov 21;17:1635. doi: 10.3332/ecancer.2023.1635. eCollection 2023. Ecancermedicalscience. 2023. PMID: 38414969 Free PMC article. Review.
Cited by
-
Aspirin attenuates YAP and β-catenin expression by promoting β-TrCP to overcome docetaxel and vinorelbine resistance in triple-negative breast cancer.Cell Death Dis. 2020 Jul 13;11(7):530. doi: 10.1038/s41419-020-2719-2. Cell Death Dis. 2020. PMID: 32661222 Free PMC article.
-
Therapeutic pattern and progress of neoadjuvant treatment for triple-negative breast cancer.Oncol Lett. 2022 May 19;24(1):219. doi: 10.3892/ol.2022.13340. eCollection 2022 Jul. Oncol Lett. 2022. PMID: 35720488 Free PMC article. Review.
-
Engineered IL-7 Receptor Enhances the Therapeutic Effect of AXL-CAR-T Cells on Triple-Negative Breast Cancer.Biomed Res Int. 2020 Jan 2;2020:4795171. doi: 10.1155/2020/4795171. eCollection 2020. Biomed Res Int. 2020. PMID: 31998790 Free PMC article.
-
Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern.Front Oncol. 2022 Mar 25;12:830124. doi: 10.3389/fonc.2022.830124. eCollection 2022. Front Oncol. 2022. PMID: 35402236 Free PMC article.
-
The Transcriptomic Portrait of Locally Advanced Breast Cancer and Its Prognostic Value in a Multi-Country Cohort of Latin American Patients.Front Oncol. 2022 Mar 22;12:835626. doi: 10.3389/fonc.2022.835626. eCollection 2022. Front Oncol. 2022. PMID: 35433488 Free PMC article.
References
-
- Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC cancerbase No. 11. Lyon, France: International Agency for Research on Cancer; 2012. [6/4/2018]. 2013] [ http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx]
Publication types
LinkOut - more resources
Full Text Sources